Early nociceptive events influence the temporal profile, but not the magnitude, of the tonic response to subcutaneous formalin: Effects with remifentanil

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 876-883

  Taylor, Bradley K ^a   Alex Peterson, M ^a   Basbaum, Allan I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALOXONE; EPSILON OPIATE RECEPTOR; FORMALDEHYDE; HALOTHANE; N METHYL DEXTRO ASPARTIC ACID; OPIATE ANTAGONIST; PENTOBARBITAL; REMIFENTANIL;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY CATHETERIZATION; ARTICLE; CARDIOVASCULAR RESPONSE; CONTINUOUS INFUSION; DATA ANALYSIS; DOSE RESPONSE; HYPOTHESIS; MALE; NERVE POTENTIAL; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; STATISTICAL ANALYSIS;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANESTHESIA, INHALATION; ANIMALS; BLOOD PRESSURE; FORMALDEHYDE; HALOTHANE; HEART RATE; INJECTIONS, INTRAVENOUS; MALE; NALOXONE; PAIN; PIPERIDINES; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 15444355528     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ABRAM, S. E. AND OLSON, E. E.: Systemic opioids do not suppress spinal sensitization after subcutaneous formalin in rats. Anesthesiology 80: 1114-1119, 1994.
2. ABRAM, S. E. AND YAKSH, T. L.: Morphine, but not inhalation anesthesia, blocks post-injury facilitation. Anesthesiology 78: 713-721, 1993.
3. ANTONIJEVIC, I., MOUSA, S. A., SCHAFER, M. AND STEIN, C.: Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci. 15: 165-172, 1995.
4. BARBER, A. AND GOTTSCHLICH, R.: Opioid agonists and antagonists: An evaluation of their peripheral actions in inflammation. Med. Res. Rev. 12: 525-562, 1992.
5. BEDERSON, J. B., FIELDS, H. L. AND BARBARO, N. M.: Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla. Somatosens. Motor Res. 7: 185-203, 1990.
6. BOWER, S. AND HULL, C. J.: The comparative pharmacokinetics of fentanyl and alfentanil. Br. J. Anaesth. 54: 871-877, 1982.
7. CERVERO, F.: Visceral pain: Mechanisms of peripheral and central sensitization. Ann. Med. 27: 235-239, 1995.
8. CODERRE, T. J., KATZ, J., VACCARINO, A. L. AND MELZACK, R.: Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence. Pain 52: 259-285, 1993.
9. DALLEL, R., RABOISSON, P., CLAVELOU, P., SAADE, M. AND WODA, A.: Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin. Pain 61: 11-6, 1995.
10. DERSHWITZ, M., RANDEL, G. I., Rosow, C. E., FRAGEN, R. J., CONNORS, P. M., LIBRIJO, E. S., SHAW, D. L., PENG, A. W. AND JAMERSON, B. D.: Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth. Analg. 81: 619-623, 1995.
11. DICKENSON, A. H. AND SULLIVAN, A. F.: Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: Different responses to an intrathecal opiate administered pre- or post-formalin. Pain 30: 339-348, 1987.
12. DUBUISSON, D. AND DENNIS, S. G.: The formalin test: A quantitative study of the analgesic effects of morphine, meperidine and brainstem stimulation in rats and cats. Pain 4: 161-174, 1977.
13. EGAN, T. D., LEMMENS, J. M., FISET, P., HERMANN, D. J., MUIR, K. T., STANSKI, D. R. AND SHAKER, S. L.: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 79: 881-892, 1993.
14. FELDMAN, P. L., JAMES, M. K., BRACKEEN, M. F., BILOTTA, J. M., SCHUSTER, S. V., LAKEY, A. P., LUTZ, M. W., JOHNSON, M. R. AND LEIGHTON, H. J.: Design synthesis and pharmacological evaluation of ultrashort- to long-acting opioid analgesics. J. Med. Chem. 34: 2202-2208, 1991.
15. FIELDS, H. L., EMSON, P., LEIGH, B., GILBERT, R. AND IVERSEN, L. L.: Multiple opiate receptor sites on primary afferent fibers. Nature (Lond.) 284: 351-353, 1980.
16. GILRON, I. AND CODERRE, T. J.: Effects of pre- and post-treatment with intravenous anesthetic agents on nociceptive behaviors in the rat formalin test (Abstract). Soc. Neurosci. 21: 1412, 1995.
17. GLASS, P. S. A.: Remifentanil: A new opioid. J. Clin. Anesth. 7: 558-563, 1995.
18. GLASS, P. S. A., HARDMAN, D., KAMIYAMA, Y., QUILL, T. J., MARTON, G., DON, K. H., GROSSE, C. M. AND HERMANN, D.: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B). Anesth. Analg. 77: 1031-1040, 1993.
19. GOTO, T., MAROTA, J. A. AND CROSBY, G.: Nitrous oxide induces preemptive analgesia in the rat that is antagonized by halothane, Anesthesiology 80: 409-416, 1994.
20. HAIDAR, S. H., MORETON, J. E., LIANG, Z. M., HOKE, J. F., MUIR, K. T. AND EDDINGTON, N. D.: Pharmacodynamics of remifentanil, a novel ultra-short-acting opioid anesthetic, using EEG in male Sprague-Dawley rats (Abstract). Soc. Neurosci. 22: 1312, 1996.
21. HALEY, J. E., SULLIVAN, A. F. AND DICKENSON, A. H.: Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain. Res. 518: 218-226, 1990.
22. HARGREAVES, K., DUBNER, R., BROWN, R., FLORES, C. AND JORIS, J.: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88, 1988.
23. HONG, Y. AND ABBOTT, F. V.: Peripheral opioid modulation of pain and inflammation in the formalin test. Eur. J. Pharm. 277: 21-28, 1995.
24. JORIS, J., COSTELLO, A., DUBNER, R. AND HARGREAVES, K. M.: Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 43: 95-103, 1990.
25. KAPLAN, H. AND FIELDS, H. L.: Hyperalgesia during acute opioid abstinence: Evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J. Neurosci. 11: 1433-1439, 1991.
26. KAYSER, V., BENOIST, J. M., NEIL, A., GAUTRON, M. AND GUILBAUD, G.: Behavioral and electrophysiological studies on the paradoxical antinociceptive effects of an extremely low dose of naloxone in an animal model of acute and localized inflammation. Exp. Brain Res. 73: 402, 1988.
27. KAYSER, V. AND GUILBAUD, G.: Dose-dependent analgesic and hyperalgesic effects of systemic naloxone in arthritic rats. Brain. Res. 226: 344-348, 1981.
28. LEMMENS, H. J. M.: Pharmacokinetic-pharmacodynamic relationships for opi- oids in balanced anesthesia. Clin. Pharmacokinet. 29: 231-242, 1995.
29. LEVINE, J. D., GORDON, N. C. AND FIELDS, H. L.: Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature (Lond.) 278: 740-741, 1979.
30. MCCALL, W. D., TANKER, K. D. AND LEVINE, J. D.: Formalin induces biphasic activity in C-fibers in the rat. Neurosci. Lett. 208: 45-48, 1996.
31. O'CONNOR, T. C. AND ABRAUM, S. E.: Halothane enhances suppression of spinal sensitization by intrathecal morphine in the rat formalin test. Anesthesiology 81: 1277-1283, 1994.
32. O'CONNOR, T. C. AND ABKAM, S. E.: Inhibition of nociception-induced spinal sensitization by anesthetic agents. Anesthesiology 82: 259-266, 1995.
33. OLUYOMI, A. O., HART, S. L. AND SMITH, T. W.: Differential antinociceptive effects of morphine and methylmorphine in the formalin test. Pain 49: 415-418, 1992.
34. PUIG, S. AND SORKIN, L. S.: Formalin-evoked activity in identified primary afferent fibers: Systemic lidocaine suppresses phase-2 activity. Pain 64: 345-355, 1996.
35. SELTZER, Z., BEILIN, B., GINZBURG, R., PARAN, Y. AND SHIMKO, T.: The role of injury discharge in the induction of neuropathic pain behavior in rats. Pain 46: 327-336, 1991.
36. STEIN, C., HASSAN, H. S., PRZEWLOCKI, R., GRAMSCH, C., PETER, K. AND HERZ, A.: Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. (U.S.A.) 87: 5935-5939, 1990.
37. TAYLOR, B., PETERSON, M. A. AND BASBAUM, A.: Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input. J. Neurosci. 15: 7575-7584, 1995a.
38. TAYLOR, B. K., ABBADIE, C., PETERSON, M. A. AND BASBAUM, A. I.: The contribution of central sensitization to persistent behavioral and cardiovascular responses and to c-Fos expression in the formalin test: Effects of remifentanil (Abstract). Amer. Pain Soc. 14: A-51, 1995b.
39. TAYLOR, B. K., HOLLOWAY, D. H. AND PRINTZ, M. P.: A unique cholinergic deficit in the spontaneously hypertensive rat: Physostigmine reveals a bradycardia response associated with sensory stimulation. J. Pharmacol. Exp. Ther. 268: 1081-1090, 1994.
40. TJOLSEN, A., BERGE, O. -G., HUNSKAAR, S., ROSLAND, J. H. AND HOLE, K.: The formalin test: An evaluation of the method, Pain 51: 5-17, 1992.
41. VACCARINO, A. L., TASKER, R. A. R. AND MELZACK, R.: Systemic administration of naloxone produces analgesia in BALB/c mice in the formalin pain test. Neurosci. Lett. 84: 103-107, 1988.
42. WESTMORLAND, C. L., HOKE, J. F., SEBEL, P. S., HUG, C. C. AND Mum, K. T.: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 79: 893-903, 1993.
43. WHEELER-ACETO, H. AND COWAN, A.: Neurogenic and tissue-mediated components of formalin-induced edema: Evidence for supraspinal regulation. Agents and Actions 34: 264-269, 1991.
44. WOOLF, C. J.: Evidence for a central component of post-injury pain hypersen- sitivity. Nature (Lond.) 308: 686-688, 1983.
45. WOOLF, C. J. AND CHONG, C.: Preemptive analgesia - treating postoperative pain by preventing the establishment of central sensitization. Anesth. Analg. 77: 362-379, 1993.
46. YAKSH, T. L.: Substance P release from knee joint afferent terminals: Modulation by opioids. Brain Res. 458: 319-324, 1988.
47. YOUNG, W. S., WAMSLEY, J. K., ZARBIN, M. A. AND KUHAR, M. J.: Opiate receptors undergo axonal flow. Science (Wash. DC) 210: 76-77, 1980.